Exhibit 10.34
NEITHER THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE
NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT,
OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS
AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY
TO THE COMPANY. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES. NO REPRESENTATION IS MADE BY THE ISSUER AS
TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE
SECURITIES ACT FOR RESALES OF THESE SECURITIES.
CYTORI THERAPEUTICS,
INC.
WARRANT TO PURCHASE COMMON
STOCK
|
|
|
|
|
Warrant No.
___
|
|
Original Issue Date: _________,
2008
|
Cytori
Therapeutics, Inc., a Delaware corporation (the “
Company ”), hereby certifies that, for value received,
[_______________] or its permitted registered assigns (the “
Holder ”), is entitled to purchase from the Company up
to a total of [_____________ (__________)] shares of common stock,
$0.001 par value per share (the “ Common Stock
”), of the Company (each such share, a “ Warrant
Share ” and all such shares, the “ Warrant
Shares ”) at an exercise price per share equal to $8.50
per share (as adjusted from time to time as provided in Section 9
herein, the “ Exercise Price ”), at any time and
from time to time after the date that is six months from the date
hereof (the “ Trigger Date ”) and through and
including 5:30 P.M., New York City time, on ____________, 2013 (the
“ Expiration Date ”), and subject to the
following terms and conditions:
This Warrant
(this “ Warrant ”) is one of a series of similar
warrants issued pursuant to that certain Securities Purchase
Agreement, dated August 7, 2008, by and among the Company and the
Purchasers identified therein (the “ Purchase
Agreement ”). All such warrants are referred
to herein, collectively, as the “ Warrants
.”
1.
Definitions . In addition to the terms defined elsewhere in
this Warrant, capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Purchase
Agreement.
2.
Registration of Warrants . The Company shall
register this Warrant, upon records to be maintained by the Company
for that purpose (the “ Warrant Register ”), in
the name of the record Holder (which shall include the initial
Holder or, as the case may be, any registered assignee to which
this Warrant is permissibly assigned hereunder) from time to
time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose
of any exercise hereof or any distribution to the Holder, and for
all other purposes, absent actual notice to the
contrary.
3.
Registration of Transfers . Subject to the restrictions on
transfer set forth in Section 4.1 of the Purchase Agreement and
compliance with all applicable securities laws, the Company shall
register the transfer of all or any portion of this Warrant in the
Warrant Register, upon surrender of this Warrant, with the Form of
Assignment attached as Schedule 2 hereto duly completed and
signed, to the Company’s transfer agent or to the Company at
its address specified in the Purchase Agreement and (x) delivery,
at the request of the Company, of an opinion of counsel reasonably
satisfactory to the Company to the effect that the transfer of such
portion of this Warrant may be made pursuant to an available
exemption from the registration requirements of the Securities Act
and all applicable state securities or blue sky laws and (y)
delivery by the transferee of a written statement to the Company
certifying that the transferee is an “accredited
investor” as defined in Rule 501(a) under the Securities Act
and making the representations and certifications set forth in
Section 3.2(b), (c), (d) and (f) of the Purchase Agreement, to the
Company at its address specified in the Purchase Agreement. Upon
any such registration or transfer, a new warrant to purchase Common
Stock in substantially the form of this Warrant (any such new
warrant, a “ New Warrant ”) evidencing the
portion of this Warrant so transferred shall be issued to the
transferee, and a New Warrant evidencing the remaining portion of
this Warrant not so transferred, if any, shall be issued to the
transferring Holder. The acceptance of the New Warrant by the
transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations in respect of the
New Warrant that the Holder has in respect of this Warrant. The
Company shall prepare, issue and deliver at its own expense any New
Warrant under this Section 3.
4.
Exercise and Duration of Warrant .
(a) All
or any part of this Warrant shall be exercisable by the registered
Holder in any manner permitted by Section 10 of this Warrant at any
time and from time to time on or after the Trigger Date and through
and including 5:30 P.M. New York City time, on the Expiration Date.
At 5:30 P.M., New York City time, on the Expiration Date, the
portion of this Warrant not exercised prior thereto shall be and
become void and of no value and this Warrant shall be terminated
and no longer outstanding.
(b) The
Holder may exercise this Warrant by delivering to the Company (i)
an exercise notice, in the form attached as Schedule 1
hereto (the “ Exercise Notice ”), completed and
duly signed, and (ii) payment of the Exercise Price for
the number of Warrant Shares as to which this Warrant is being
exercised (which may take the form of a “cashless
exercise” if so indicated in the Exercise Notice and if a
“cashless exercise” may occur at such time pursuant to
Section 10 below), and the date such items are delivered to the
Company (as determined in accordance with the notice provisions
hereof) is an “ Exercise Date .” The delivery by
(or on behalf of) the Holder of the Exercise Notice and the
applicable Exercise Price as provided above shall constitute the
Holder’s certification to the Company that its
representations contained in Section 3.2(b), (c), (d) and (f) of
the Purchase Agreement are true and correct as of the Exercise Date
as if remade in their entirety (or, in the case of any transferee
Holder that is not a party to the Purchase Agreement, such
transferee Holder’s certification to the Company that such
representations are true and correct as to such assignee Holder as
of the Exercise Date). The Holder shall not be required
to deliver the original Warrant in order to effect an exercise
hereunder, but if it is not so delivered then such exercise shall
constitute an agreement by the Holder to deliver the original
Warrant to the Company as soon as practicable
thereafter. Execution and delivery of the Exercise
Notice shall have the same effect as cancellation of the original
Warrant and issuance of a New Warrant evidencing the right to
purchase the remaining number of Warrant Shares.
5.
Delivery of Warrant Shares .
(a) Upon
exercise of this Warrant, the Company shall promptly (but in no
event later than three Trading Days after the Exercise Date) issue
or cause to be issued and cause to be delivered to or upon the
written order of the Holder and in such name or names as the Holder
may designate (provided that, if the Registration Statement is not
effective and the Holder directs the Company to deliver a
certificate for the Warrant Shares in a name other than that of the
Holder or an Affiliate of the Holder, it shall deliver to the
Company on the Exercise Date an opinion of counsel reasonably
satisfactory to the Company to the effect that the issuance of such
Warrant Shares in such other name may be made pursuant to an
available exemption from the registration requirements of the
Securities Act and all applicable state securities or blue sky
laws), (i) a certificate for the Warrant Shares issuable upon such
exercise, free of restrictive legends, or (ii) an electronic
delivery of the Warrant Shares to the Holder’s account at the
Depository Trust Company (“ DTC ”) or a similar
organization, unless in the case of clause (i) and (ii) a
registration statement covering the resale of the Warrant Shares
and naming the Holder as a selling stockholder thereunder is not
then effective or the Warrant Shares are not freely transferable
without restriction under Rule 144 by Holders who are not
affiliates of the Company, in which case such Holder shall receive
a certificate for the Warrant Shares issuable upon such exercise
with appropriate restrictive legends. The Holder, or any
Person permissibly so designated by the Holder to receive Warrant
Shares, shall be deemed to have become the holder of record of such
Warrant Shares as of the Exercise Date. If the Warrant
Shares are to be issued free of all restrictive legends, the
Company shall, upon the written request of the Holder, use its
reasonable best efforts to deliver, or cause to be delivered,
Warrant Shares hereunder electronically through The Depository
Trust Company or another established clearing corporation
performing similar functions, if available; provided, that, the
Company may, but will not be required to, change its transfer agent
if its current transfer agent cannot deliver Warrant Shares
electronically through such a clearing corporation.
(b)
If by the close of the third Trading Day after delivery of an
Exercise Notice and the payment of the aggregate exercise price in
any manner permitted by Section 10 of this Warrant, the Company
fails to deliver to the Holder a certificate representing the
required number of Warrant Shares in the manner required pursuant
to Section 5(a), and if after such third Trading Day and prior to
the receipt of such Warrant Shares, the Holder purchases (in an
open market transaction or otherwise) shares of Common Stock to
deliver in satisfaction of a sale by the Holder of the Warrant
Shares which the Holder anticipated receiving upon such exercise (a
“ Buy-In ”), then the Company shall, within
three (3) Trading Days after the Holder’s request and in the
Holder’s sole discretion, either (1) pay in cash to the
Holder an amount equal to the Holder’s total purchase price
(including brokerage commissions, if any) for the shares of Common
Stock so purchased (the “ Buy-In Price ”), at
which point the Company’s obligation to deliver such
certificate (and to issue such Warrant Shares) shall terminate or
(2) promptly honor its obligation to deliver to the Holder a
certificate or certificates representing such Warrant Shares and
pay cash to the Holder in an amount equal to the excess (if any) of
the Buy-In Price over the product of (A) such number of Warrant
Shares, times (B) the closing bid price of a share of Common Stock
on the Exercise Date.
(c) To
the extent permitted by law, the Company’s obligations to
issue and deliver Warrant Shares in accordance with the terms
hereof are absolute and unconditional, irrespective of any action
or inaction by the Holder to enforce the same, any waiver or
consent with respect to any provision hereof, the recovery of any
judgment against any Person or any action to enforce the same, or
any setoff, counterclaim, recoupment, limitation or termination, or
any breach or alleged breach by the Holder or any other Person of
any obligation to the Company or any
violation or
alleged violation of law by the Holder or any other Person, and
irrespective of any other circumstance that might otherwise limit
such obligation of the Company to the Holder in connection with the
issuance of Warrant Shares. Nothing herein shall limit the
Holder’s right to pursue any other remedies available to it
hereunder, at law or in equity including, without limitation, a
decree of specific performance and/or injunctive relief with
respect to the Company’s failure to timely deliver
certificates representing shares of Common Stock upon exercise of
the Warrant as required pursuant to the terms hereof.
6.
Charges, Taxes and Expenses . Issuance and delivery of
certificates for shares of Common Stock upon exercise of this
Warrant shall be made without charge to the Holder for any issue or
transfer tax, transfer agent fee or other incidental tax or expense
in respect of the issuance of such certificates, all of which taxes
and expenses shall be paid by the Company; provided, however
, that the Company shall not be required to pay any tax that may be
payable in respect of any transfer involved in the registration of
any certificates for Warrant Shares or the Warrants in a name other
than that of the Holder or an Affiliate thereof. The Holder shall
be responsible for all other tax liability that may arise as a
result of holding or transferring this Warrant or receiving Warrant
Shares upon exercise hereof.
7.
Replacement of Warrant . If this Warrant is
mutilated, lost, stolen or destroyed, the Company shall issue or
cause to be issued in exchange and substitution for and upon
cancellation hereof, or in lieu of and substitution for this
Warrant, a New Warrant, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or
destruction (in such case) and, in each case, a customary and
reasonable indemnity and surety bond, if requested by the Company.
Applicants for a New Warrant under such circumstances shall also
comply with such other reasonable regulations and procedures and
pay such other reasonable third-party costs as the Company may
prescribe. If a New Warrant is requested as a result of a
mutilation of this Warrant, then the Holder shall deliver such
mutilated Warrant to the Company as a condition precedent to the
Company’s obligation to issue the New Warrant.
8.
Reservation of Warrant Shares . The Company covenants that
it will at all times reserve and keep available out of the
aggregate of its authorized but unissued and otherwise unreserved
Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided,
the number of Warrant Shares that are then issuable and deliverable
upon the exercise of this entire Warrant, free from preemptive
rights or any other contingent purchase rights of persons other
than the Holder (taking into account the adjustments and
restrictions of Section 9). The Company covenants that all Warrant
Shares so issuable and deliverable shall, upon issuance and the
payment of the applicable Exercise Price in accordance with the
terms hereof, be duly and validly authorized, issued and fully paid
and nonassessable. The Company will take all such action as may be
reasonably necessary to assure that such shares of Common Stock may
be issued as provided herein without violation of any applicable
law or regulation, or of any requirements of any securities
exchange or automated quotation system upon which the Common Stock
may be listed.
9.
Certain Adjustments . The Exercise Price and number of
Warrant Shares issuable upon exercise of this Warrant are subject
to adjustment from time to time as set forth in this Section
9.
(a)
Stock Dividends and Splits . If the Company, at any time
while this Warrant is outstanding, (i) pays a stock dividend on its
Common Stock or otherwise makes a distribution on any class of
capital stock that is payable in shares of Common Stock, (ii)
subdivides its outstanding shares of Common Stock into a larger
number of shares, or (iii) combines its outstanding shares of
Common Stock into a smaller number of shares, then in each such
case the
Exercise Price
shall be multiplied by a fraction, the numerator of which shall be
the number of shares of Common Stock outstanding immediately before
such event and the denominator of which shall be the number of
shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to clause (i) of this paragraph shall
become effective immediately after the record date for the
determination of stockholders entitled to receive such dividend or
distribution, and any adjustment pursuant to clause (ii) or (iii)
of this paragraph shall become effective immediately after the
effective date of such subdivision or combination.
(b)
Pro Rata Distributions . If the Company, at any
time while this Warrant is outstanding, distributes to all holders
of Common Stock for no consideration (i) evidences of its
indebtedness, (ii) any security (other than a distribution of
Common Stock covered by the preceding paragraph) or (iii) rights or
warrants to subscribe for or purchase any security, or (iv) any
other asset (in each case, “ Distributed Property
”), then, upon any exercise of this Warrant that occurs after
the record date fixed for determination of stockholders entitled to
receive such distribution, the Holder shall be entitled to receive,
in addition to the Warrant Shares otherwise issuable upon such
exercise (if applicable), the Distributed Property that such Holder
would have been entitled to receive in respect of such number of
Warrant Shares had the Holder been the record holder of such
Warrant Shares immediately prior to such record date without regard
to any limitation on exercise contained therein.
(c)
Fundamental Transactions . If, at any time while this
Warrant is outstanding (i) the Company effects (A) any merger
of the Company with (but not into) another Person, in which
stockholders of the Company immediately prior to such transaction
own less than a majority of the outstanding stock of the surviving
entity, or (B) any merger or consolidation of the Company into
another Person, (ii) the Company effects any sale of all or
substantially all of its assets in one or a series of related
transactions, (iii) any tender offer or exchange offer approved or
authorized by the Company’s Board of Directors is completed
pursuant to which holders of at least a majority of the outstanding
Common Stock tender or exchange their shares for other securities,
cash or property, or (iv) the Company effects any reclassification
of the Common Stock or any compulsory share exchange pursuant to
which the Common Stock is effectively converted into or exchanged
for other securities, cash or property (other than as a result of a
subdivision or combination of shares of Common Stock covered by
Section 9(a) above) (in any such case, a “ Fundamental
Transaction ”), then the Holder shall have the right
thereafter to receive, upon exercise of this Warrant, the same
amount and kind of securities, cash or property as it would have
been entitled to receive upon the occurrence of such Fundamental
Transaction if it had been, immediately prior to such Fundamental
Transaction, the holder of the number of Warrant Shares then
issuable upon exercise in full of this Warrant without regard to
any limitations on exercise contained herein (the “
Alternate Consideration ”), and the Holder shall no
longer have the right to receive Warrant Shares upon exercise of
this Warrant. The Company shall not effect any such
Fundamental Transaction unless prior to or simultaneously with the
consummation thereof, any successor to the Company, surviving
entity or the corporation purchasing or otherwise acquiring such
assets or other appropriate corporation or Person shall assume the
obligation to deliver to the Holder, such Alternate Consideration
as, in accordance with the foregoing provisions, the Holder may be
entitled to receive, and the other obligations under this
Warrant. The provisions of this paragraph (c) shall
similarly apply to subsequent transactions analogous of a
Fundamental Transaction type. Notwithstanding the
foregoing, in the event of a Fundamental Transaction in which the
consideration consists of substantially all cash or securities of a
private company, at the request of the Holder delivered before the
20th day after such Fundamental Transaction, the Company (or the
successor entity) shall purchase this Warrant from the Holder by
paying to the Holder, within five Business Days after such request
(or, if later, on the effective date of the Fundamental
Transaction), cash in an amount equal to the Black
Scholes Value
(as defined below) of the remaining unexercised portion of this
Warrant on the date of such Fundamental Transaction. For
purposes hereof, “Black Scholes Value” means the value
of this Warrant based on the Black and Scholes Option Pricing Model
obtained from the “OV” function on
Bloomberg Financial Markets (“Bloomberg”)
determined as of the day immediately following the public
announcement of the applicable Fundamental Transaction and
reflecting (i) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the remaining term of this
Warrant as of such date of request and (ii) an expected volatility
equal to the greater of 50% and the 100 day volatility obtained
from the HVT function on Bloomberg.
(d)
Number of Warrant Shares . Simultaneously with any
adjustment to the Exercise Price pursuant to paragraph (a) and (e)
of this Section 9, the number of Warrant Shares that may be
purchased upon exercise of this Warrant shall be increased or
decreased proportionately, so that after such adjustment the
aggregate Exercise Price payable hereunder for the increased or
decreased number of Warrant Shares shall be the same as the
aggregate Exercise Price in effect immediately prior to such
adjustment.
(e)
Subsequent Equity Sales .
(i) Except as provided in
subsection (e)(iii) hereof, if and whenever the Company shall issue
or sell, or is, in accordance with any of subsections (e)(ii)(l)
through (
|